Details of the Drug

General Information of Drug (ID: DMGM8JV)

Drug Name

CLBS16

Indication

Disease Entry	ICD 11	Status	REF
Coronary microvascular disease	BA86	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03508609) An Open-Label Exploratory Clinical Study to Evaluate the Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction (CMD) and Without Obstructive Coronary Artery Disease. U.S.National Institutes of Health.